XML 93 R73.htm IDEA: XBRL DOCUMENT v3.26.1
Restatement of Previously Issued Audited Financial Statements - Schedule of Restated Statement of Cash Flows (Details)
 12 Months Ended
Dec. 31, 2024
USD ($)
As Previously Reported [Member]  
Schedule of Restated Statement of Cash Flows [Line Items]  
Net loss $ (29,252,284)
Loss on issuance of warrants 0
Warrant issuance costs 0
Accrued expenses, lease liabilities, and other current liabilities 10,642,938
Net cash used in operating activities 9,493,500
Proceeds from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants 22,369,285
Proceeds from issuance of warrants 0
Net cash provided by financing activities 26,584,380
Adjustments [Member]  
Schedule of Restated Statement of Cash Flows [Line Items]  
Net loss (4,083,295)
Loss on issuance of warrants 2,344,147
Warrant issuance costs 1,739,148
Accrued expenses, lease liabilities, and other current liabilities (9,652,581)
Net cash used in operating activities 9,702,581
Proceeds from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants (8,558,271)
Proceeds from issuance of warrants 18,260,852
Net cash provided by financing activities 9,702,581
As Restated [Member]  
Schedule of Restated Statement of Cash Flows [Line Items]  
Net loss (33,335,579)
Loss on issuance of warrants 2,344,147
Warrant issuance costs 1,739,148
Accrued expenses, lease liabilities, and other current liabilities 990,357
Net cash used in operating activities 19,196,081
Proceeds from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants 13,811,014
Proceeds from issuance of warrants 18,260,852
Net cash provided by financing activities $ 36,286,961